Automated research refresh updated the product evidence set.
Before: Evidence 65 · Safety 66 · Effectiveness 58 · Confidence 82
After: Evidence 65 · Safety 74 · Effectiveness 52 · Confidence 85
Differin Acne Treatment Gel, 90 Day Supply, Retinoid Treatment for Face with 0.1% Adapalene, Gentle Skin Care for Acne Prone Sensitive Skin, 45g Pump (Packaging May Vary)
Differin Gel Acne Treatment contains adapalene, an Rx-strength acne-fighting retinoid that helps clear breakouts where they start (works deep into pores in 5 minutes), helps prevents new acne from forming, and as a result, can restore skin�s overall tone...
Direct product evidence5 papers indexed · 5 claims mapped
Resar evidence panel
0–100 · cited research only
Evidence Score
65
Good
Safety Score
74
Strong
Effectiveness Score
52
Emerging
Research Confidence
85
Excellent
Product Fit Score
45
Emerging
Bottom line
Moderate evidence (Good) — promising research, but read the caveats before buying.
Product fit is weaker — dose, price, or practical use may not align with what studies tested.
Evidence Score
65
Good
Price
$23.97
Resar may earn an affiliate commission on this purchase. Commissions never change scores — see our affiliate disclosure and conflicts policy. Scores reflect cited research, not medical advice.
Compare others in SkincareTop research
The strongest studies behind this product
Ranked by evidence hierarchy and how closely each study matches this product. Start with the strongest study, then read down. Every claim needs a trail.
Strongest studyHigh-quality synthesis86% relevance
Efficacy of topical treatments for mild-to-moderate acne: A systematic review and meta-analysis of randomized control trials
Meta Analysis · Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
What the research shows
Mean lesion‑count reduction 45‑60% after 12 weeks of daily use.
Direct product evidenceRead study
2345
High-quality synthesis80% relevance
Guidelines of care for the management of acne vulgaris
Systematic Review · Journal of the American Academy of Dermatology · 2024
Direct product evidence
Human RCT74% relevance
Comparative clinical study of efficacy and safety of adapalene 0.1% gel versus benzoyl peroxide 2.5% gel for the treatment of acne vulgaris
Randomized Controlled Trial · International Journal of Basic & Clinical Pharmacology · 2019
Category-level evidence
Human RCT68% relevance
Efficacy of Topical 5% Dapsone Gel Versus 0.1% Adapalene Gel in the Treatment of Mild to Moderate Acne Vulgaris
Randomized Controlled Trial · Medical Journal of South Punjab · 2024
Category-level evidence
Indirect synthesis62% relevance
Topical Retinoids in Acne Vulgaris: A Systematic Review
Systematic Review · American journal of clinical dermatology · 2019
Category-level evidence
Scores reflect these cited studies, not medical advice. Expand the full evidence detail below for protocols, dose context, and reported side effects.
Did this clinical breakdown make sense?
Share this evidence report
Send a link to this page so others can read the same breakdown.
Claim ledger
Every claim, mapped to its source
Each product claim below is tied to a specific paper with study type, match strength, and limitations. Nothing here is medical advice — it is a research trail you can audit.
Claim match reflects how closely a specific paper supports this benefit — not AI confidence or medical certainty.
ClaimEvidence directnessMatchStudy type
Full evidence detail
Study-by-study breakdown
Each paper below is ranked for this listing. Start with the highest match, then expand any study for a plain-language readout.
How to read this section
- Match % - how closely the study matches this product (not overall scientific quality).
- Evidence type - study design (RCT, review, etc.) and whether it is direct, category-level, or indirect.
- What it found - short summary and quoted extract from the paper metadata. Not medical advice.
Direct product evidenceThis study closely matches this product or its active ingredient.
In plain language
The review pooled 28 RCTs and found adapalene 0.1% gel ranked among the most effective agents, achieving statistically significant reductions in both inflammatory and non‑inflammatory lesions compared with placebo and comparable to other retinoids. [1]
What the study reported
Verified extract — not AI generated
“Mean lesion‑count reduction 45‑60% after 12 weeks of daily use.”
How it was used
Apply a pea‑sized amount to the entire face once daily in the evening for at least 12 weeks.
Side effects noted
Mild irritation, dryness, or erythema reported in ~15 % of users; most events were transient.
Caveats
Heterogeneity among included trials and varying outcome measures limit precise effect size estimation.
Transparency
Score history
Human review is pending for this listing.
Reviews
Shopper feedback
4.6
average rating
10,414 Amazon reviews were available from the listing metadata.